This topic contains a solution. Click here to go to the answer

Author Question: A 20-kg child has been taking valproic acid Depakote for 1 week to treat a seizure disorder. The ... (Read 39 times)

geodog55

  • Hero Member
  • *****
  • Posts: 530
A 20-kg child has been taking valproic acid Depakote for 1 week to treat a seizure disorder. The child is receiving 200 mg PO twice daily. The child's parents report no improvement in sei-zure activity.
 
  The nurse will anticipate that the provider will order which change in this child's drug regimen? a. Adding another seizure medication to supplement the valproic acid
  b. Changing to phenytoin Dilantin since the valproic acid is not effective
  c. Increasing the dose of valproic acid to 300 mg PO twice daily
  d. Increasing the dose of valproic acid to 200 mg three times daily

Question 2

A patient is taking enalapril Vasotec. The nurse understands that patients taking this type of drug for heart failure need to be monitored carefully for:
 
  a. hypernatremia.
  b. hypertension.
  c. hyperkalemia.
  d. hypokalemia.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

LegendaryAnswers

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

C
Valproic acid is given initially at a dose of 5 to 15 mg/kg/day, administered in two divided doses. This child is receiving 400 mg/day, which is 10 mg/kg/day. The dosage should be increased by 5 to 10 mg/kg/day each week until optimal levels are achieved up to a maximum dose of 60 mg/kg/day. At this point, adding another AED or changing to another AED is not recommended. Increasing the dose to three times daily is not recommended.

Answer to Question 2

C
One of the principal effects of angiotensin-converting enzyme (ACE) inhibitors is hyperkalemia, which is due to decreased aldosterone release arising from blockage of angiotensin II. There is no indication that careful monitoring of sodium for increased levels is indicated. Vasotec is indi-cated for heart failure, not hypertension. The drug therapy should be monitored to ascertain its effectiveness, but hyperkalemia is the main concern. Hyperkalemia, not hypokalemia, is a concern because of the decreased aldosterone release that occurs with blockage of angiotensin II.




geodog55

  • Member
  • Posts: 530
Reply 2 on: Jul 23, 2018
Wow, this really help


steff9894

  • Member
  • Posts: 337
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

A cataract is a clouding of the eyes' natural lens. As we age, some clouding of the lens may occur. The first sign of a cataract is usually blurry vision. Although glasses and other visual aids may at first help a person with cataracts, surgery may become inevitable. Cataract surgery is very successful in restoring vision, and it is the most frequently performed surgery in the United States.

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

For a complete list of videos, visit our video library